Home ›› Cancer Programs ›› Gynecologic Research & Publications

2014

Full Articles Published or Accepted in Peer-Reviewed Journals/Books

  • Berek JS, Edwards RP, Parker LP, DeMars LR, Herzog TJ, Lentz SS, Morris RT, Akerley WL, Holloway RW, Method MW, Plaxe SC, Walker JL, Friccius-Queche H, Krasner CN. Catumaxomab for the treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: A phase II study. Int. J. Gynecol. Cancer 2014; 24: 1583-1589.
  • Grendys EC Jr, Florica JV, Orr JW Jr, Holloway RW, Wang D, Tian C, Chan J, Herzog TJ. Overview of a chemoresponse assay in ovarian cancer. Clin. Transl. Oncol. 2014; 16: 761-769.
  • Gubbi A, Kendrick JE, Finkler NJ. The role of bevacizumab in recurrent, platinum-sensitive ovarian cancer. Expert Rev. Anticancer. Ther. 2014; 14: 1105-1113.
  • James JA, Rakowski JA, Jeppson CN, Stavitzski NM, Ahmad S, Holloway RW. Robotic transperitoneal infra-renal aortic lymphadenectomy in early-stage endometrial cancer. Gynecol. Oncol. 2014; Dec. 27; In Press. DOI: org/10.1016/j.ygyno.2014.12.028.
  • Han L, Wang W, Lu J, Kong F, Ma G, Zhu Y, Zhao D, Zhu J, Shuai W, Zhou Q, Chen P, Ye L, Tao J, Ahmad S, Li F, Sun J. AAV-sBTLA facilitates HSP70 vaccine-triggered prophylactic antitumor immunity against a murine melanoma pulmonary metastasis model in vivo. Cancer Lett. 2014; 354: 398-406.
  • Hudry D, Ahmad S, Zanagnolo V, Narducci F, Fastrez M, Ponce J, Tucher E, Lécuru F, Conri V, Leguevaque P, Goffin F, Holloway RW, Lambaudie E, Köhler C, Leblanc E, Maggioni A, Vergote I, Houvenaeghel G. Robotically-assisted para-aortic lymphadenectomy: Surgical results - A cohort study of 487 patients. Int. J. Gynecol. Cancer 2014; In Press. DOI: 10.1097/IGC.0000000000000373.
  • Al-Husaini H, Hussein H, Darwish A, Ahmed M, Eltigani A, Edesa W, Elhassan T, Omar A, Elghamry W, Al-Hashem H, Al-Hayli S, Madkhali I, Ahmad S, Al-Badawi IA. Gestational trophoblastic neoplasia: Treatment outcomes from a single institutional experience. Clin. Transl. Oncol. 2014; Nov. 15, In Press. DOI 10.1007/s12094-014-1251-1.
  • Al-Badawi IA, Alshankiti H, Ahmad S. Single incision laparoscopic surgery in pregnancy. CRSLS (Case Report - Society of Laparoendoscopic Surgery): 2014; e2014.00404. DOI: 10.4293/CRSLS.2014.00404.
  • Ansari A, Ahmad S, James JA, Jeppson CN, Holloway RW. Robotic-assisted laparoscopic resection of cornual ectopic pregnancy: Description of a surgical technique and review of the literature. J. Reprod. Med. 2014; In Press.
  • Tetik S, Kılıç A, Aksoy H, Rizaner N, Ahmad S, Yardimci KT. Oxidative stress causes plasma protein modification. Indian J. Exp. Biol. 2014; In Press.
  • Al-Badawi IA, Alshankiti H, Ahmad S. Single incision laparoscopic surgery in pregnancy: A case report and review of the literature. In: Proceedings of the 18th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI), October 24-27, 2013, Vienna, Austria; Monduzzi Editoriale: International Proceedings Division (Ben-Rafael Z, Ed.), Bologna, Italy, 2014; pp. 271-276.
  • Holloway RW, James JA, Ahmad S. Robotic transperitoneal aortic lymphadenectomy: Experience with a single center-docked configuration. In: Robotics in Gynecology (Magrina JF, Kho R, Advincula A, Eds.), Wiley & Sons, Hoboken, NJ, 2014; In Press.
  • Kendrick JE IV, Ahmad S, Holloway RW. Robotic pelvic and aortic lymphadenectomy for gynecologic malignancies – One approach. In: Robotic Surgery: Practical Examples in Gynecology (Kilic SG, Ertan AK, Kose MF, Eds.), de Gruyter Publisher, Berlin, 2014; pp. 221-236.

Abstracts Presented at National / International Meetings

  • Holloway RW. Surgical and technical innovations in gynecologic oncology. Invited Lecture at the 21st Hong Kong International Cancer Congress (November 21, 2014), Hong Kong.
  • Ahmad S. Lifestyle and risk of gynecologic cancers. Invited Lecture at the Symposium on Obstetrics, Gynecology & Reproductive Medicine, organized by the King Faisal Specialist Hospital & Research Center (November 11-13, 2014), Riyadh, Saudi Arabia. Also, served as Co-moderator for the “Workshop on Epidemiology of Gynecology Oncology”.
  • Ahmad S, Holloway RW. Development of clinical outcomes research skills in gynecology/oncology. Oral Presentation at the “Junior SEERSS” Session of the 3rd International Congress in Robotic Surgery, Organized by the South Eastern European Robotic Surgery Society (SEERSS), (October 2-4, 2014), Sofia, Bulgaria
  • Ahmad S, Holloway RW. Robotic research in gynecology/oncology: Florida Hospital experience. Oral Presentation at the “Gynecology I” Session of the 3rd International Congress in Robotic Surgery, Organized by the South Eastern European Robotic Surgery Society (SEERSS), (October 2-4, 2014), Sofia, Bulgaria
  • Ahmad S. Hypercoagulability in ovarian cancer: Laboratory and clinical perspectives. Plenary Lecture at the 4th International Meeting on Pharmacy & Pharmaceutical Sciences, IMPPS-4 (September 18-21, 2014), Istanbul, Turkey (PL-44).
  • Holloway RW, James JA, Jeppson CN, Gubbi A, Takimoto EL, Stavitzski NM, Ahmad S. Pelvic sentinel lymph node status and risk of aortic nodal metastasis in patients with endometrial cancer. Poster Presentation at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO), May 30-June 3, 2014, Chicago, IL; A-5597.
  • Makker V, Filiaci VL, Chen L-M, Darus C, Kendrick JE, Sutton G, Moxley K, Aghajanian C. Phase II evaluation of dalantercept, a soluble recombinant active receptor-like kinase 1 (ALK1) receptor fusion protein, for treatment of recurrent/persistent endometrial cancer: GOG-0229N. Poster Presentation at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO), May 30-June 3, 2014, Chicago, IL; A-5594.
  • Sankpal UT, Ingersoll SB, Bhat VB, Ahmad S, Holloway RW, Basha R. Relevance of Sp1 and survivin expression in epithelial ovarian cancer patients and their usefulness as potential therapeutic targets. Poster Presentation at the 105th Annual Meeting of the American Association for Cancer Research (AACR). Proc. Am. Assoc. Cancer Res. 2014; A-1354.
  • James JA, Jeppson CN, Gubbi A, Takimoto EL, Stavitzski NM, Ahmad S, Holloway RW. Pelvic sentinel lymph node mapping and aortic nodal status in endometrial cancer: Does infra-renal aortic lymph node metastasis really occur in isolation? Poster Presentation at the 45th Annual Meeting on Women’s Cancer of the Society of Gynecologic Oncology (SGO), March 22-25, 2014, Tampa, FL; A-336.
  • Jeppson CN, James JA, Gubbi A, Kendrick JE, Ahmad S, Holloway RW. Weight loss in preparation for robotic-assisted surgery in the management of low-grade stage I uterine carcinoma: Clinical outcomes. Poster Presentation at the 45th Annual Meeting on Women’s Cancer of the Society of Gynecologic Oncology (SGO), March 22-25, 2014, Tampa, FL; A-425.
  • Holloway RW, Bigsby GE, Ghurani GB, Kendrick JE, James JA, Jeppson CN, Gubbi A, Stavitzski NM, Ahmad S. Robotic surgery 6-year analysis of annual peri-operative outcomes for patients with endometrial cancer. Poster Presentation at the 45th Annual Meeting on Women’s Cancer of the Society of Gynecologic Oncology (SGO), March 22-25, 2014, Tampa, FL; A-500.
  • Ingersoll SB, Srivastava M, Ali G, Mohiuddin Z, Boone ER, Ahmad S, Banks RK, Finkler NJ, Edwards JR, Holloway RW. Cytokine-induced killer cells from ovarian cancer patients expanded ex vivo in the presence of IL-7 improve survival in a xenograft mouse model of ovarian cancer. Poster Presentation at the 45th Annual Meeting on Women’s Cancer of the Society of Gynecologic Oncology (SGO), March 22-25, 2014, Tampa, FL; A-296.
  • Ahmad S. Hypercoagulability in ovarian cancer: Laboratory and clinical perspectives.  Abstracts & Program Book of the 5th International Conference on Traslational Cancer Research, February 6-9, 2014, Vigyan Bhawan, New Delhi; P-20.
  • Basha R, Ingersoll SB, Sankpal UT, Bhat VB, Holloway RW, Ahmad S. Targeting Sp1 and surviving for enhancing the therapeutic efficacy in epithelial ovarian cancer. Abstracts & Program Book of the 5th International Conference on Traslational Cancer Research, February 6-9, 2014, Vigyan Bhawan, New Delhi; S-45.

Invited Lectures, Presentations at National & International Conferences

  • Robert W. Holloway, MD. Invited Speaker at the 21st Hong Kong International Cancer Congress (November 21, 2014), Hong Kong.
  • Sarfraz Ahmad, PhD - Invited Speaker at the Symposium on Obstetrics, Gynecologic and Reproductive Medicine in Saudi Arabia: Challenges and Opportunities, Organized by the King Faisal Specialist Hospital & Research Center (November 11-13, 2014), Riyadh, Saudi Arabia
  • Robert W. Holloway, MD and Sarfraz Ahmad, PhD - Invited Speakers & Academic Advisory Board Member, at the 3rd International Congress in Robotic Surgery, Organized by the South Eastern European Robotic Surgery Society, SEERSS (October 3-4, 2014), Sofia, Bulgaria
  • Sarfraz Ahmad, PhD - Invited Plenary Speaker at the 4th International Meeting on Pharmacy & Pharmaceutical Sciences, IMPPS-4  (September 18-21, 2014), Istanbul, Turkey
  • Robert W. Holloway, MD – Invited Speaker at the “Best of ASCO”Annual Meeting, Organized by the Florida Hospital Cancer Institute (June 28-29, 2014), Orlando, FL
  • Robert W. Holloway, MD and Sarfraz Ahmad, PhD - Poster Presenters at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO), (May 30-June 3, 2014), Chicago, IL
  • Robert W. Holloway, MD – Invited Speaker
  • Robert W. Holloway, MD - Invited Speaker at the 3rd Biennial “Miami Robotics Symposium”, Organized by the Baptist Health South Florida, April 2014,  Miami, FL
  • Robert W. Holloway MD, James E. Kendrick MD, Lorna A. Brudie DO, Corinne N. Jeppson DO, Ajit Gubbi DO, Sarfraz Ahmad PhD - Scientific Posters Presenters at the 45th Annual Meeting on Women’s Cancer, Society of Gynecologic Oncology, SGO (March 22-25, 2014), Tampa, FL
  • Robert W. Holloway, MD - Invited Guest Lecturer, Three Presentations at the Japanese Robotic Society Meeting (JROBO), January 2014,  Fukuoka, Japan
Back to Top

2013

  • Sabbatini P, Harter P, Scambia G, Sehouli J, Meier W, Wimberger P, Baumann KH, Kurzeder C, Schmalfeldt B, Cibula D, Bidzinski MW, Herraez AC, Martoni AA, Colombo N, Holloway RW, Selvaggi L, Li AJ, del Campo JM, Cwiertka K, Pinter T, Vermorken JB, Pujade-Lauraine E, Scartoni S, Bertolott M, Simonelli C, Capriati A, Maggi CA, Berek JS, Pfisterer J. Abagovoman as maintenance therapy in patients with epithelial ovarian cancer: A phase III trial of the AGO OVAR, COGI, GINECO, and GEICO--The MIMOSA Study. Journal of Clinical Oncology 2013; 32: 1554-1561.
  • Alvarez EA, Brady WE, Walker J, Rotmensch J, Zhou XC, Kendrick JE, Yamada SD, Schilder JM, Cohn D, Harrison CR, Moore KN, Aghajanian C. Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study. Gynecologic Oncology 2013; 129: 22-27.
  • Tran TA, Holloway RW. Primary peritoneal low-grade serous carcinoma forming a mass in the colon mimicking a colonic primary carcinoma: A case report. European Journal of Gynaecological Oncology 2013; 34: 86-89.
  • Colombo N, McMeekin DS, Schwartz PE, Sessa C, Gehrig PA, Holloway RW, Braly P, Matei D, Einstein MH, Morosky A, Dodion PF, Haluska F. Ridaforolimus as a single agent in advanced endometrial cancer: Results of a single-arm, phase 2 trial. British Journal of Cancer 2013; 108: 1021-1026.
  • Brudie LA, Backes FJ, Ahmad S, Zhu X, Finkler NJ, Bigsby IV GE, Cohn DE, O,Malley D, Fowler JM, Holloway RW. Analysis of disease recurrence and survival of women with uterine malignancies undergoing robotic surgery. Gynecologic Oncology 2013; 128: 309-315.
  • Tetik S, Ermengu E, Ak K, Tekkeşin N, Ahmad S, Yardimci KT. Evaluations of haemostatic alterations in coronary artery bypass graft patients before and after angiography using thrombelastography. Current Trends in Biotechnology & Pharmacy 2013; 7: 492-498.
  • Al-Badawi IA, Munkarah AR, Tulbah A, Babic II, Al-Kuraya K, Ahmad S. A detailed study of patients and tumor characteristics of epithelial ovarian cancer in Saudi women. International Journal of Gynecological Cancer 2013; 23: 456-460.
  • Secord AA, Geller MA, Broadwater G, Holloway RW, Shuler K, Dao N-y, Gehrig PA, O’Malley DM, Finkler NJ, Havrilesky LJ. A multicenter evaluation of adjuvant therapy in women with optimally rected stage IIIC endometrial cancer. Gynecologic Oncology 2013; 128: 65-70.
  • Amirkhosravi A, Bigsby G IV, Desai H, Rivera-Amaya M, Coll E, Robles-Carrillo L, Faust P, Waters A, Meyer T, Reyes E, Langer F, Francis JL. Blood clotting activation analysis for preoperative differentiation of benign versus malignant ovarian masses.Blood Coagulation & Fibrinolysis. 2013; In Press.
  • Holloway RW, James JA, Ahmad S. Robotic transperitoneal aortic lymphadenectomy: Experience with a single center-docked configuration. In: Robotics in Gynecology (Magrina JF, Kho R, Advincula A, Eds.), Wiley & Sons, Hoboken, NJ, 2013; In Press.
  • Kendrick JE IV, Ahmad S, Holloway RW. Robotic pelvic and aortic lymphadenectomy for gynecologic malignancies – One approach. In: Robotic Gynecologic Surgery (Kilic SG, Ertan K, Kose F, Eds.), European Publisher, First Edition, 2013; In Press.
  • Backes FJ, Holloway RW, Fowler JM. Strategies for avoiding complications from robotic gynecologic surgery. In: Robotic Gynecologic Surgery (Kilic SG, Ertan K, Kose F, Eds.), European Publisher, First Edition, 2013; In Press.
Back to Top

2012

  • Rakowski JA, Tran TAN, Ahmad S, James JA, Brudie LA, Pernicone PJ, Radi MJ. Holloway RW. Does a uterine manipulator affect cervical cancer pathology or identification of lymphovascular space involvement? Gynecologic Oncology 2012; 127: 98-101.
  • Kaye S, Fehrenbacher L, Holloway RW, Amit A, Karlan BY, Slomovitz B, Sabbatini P, Fu L, Yauch RL, Chang I, Reddy JC. A phase II, randomized, placebo-controlled study of vismodegib as maintenance therapy in patients with OC in second or third complete remission. Clinical Cancer Research 2012; 18: 6509-6518.
  • Tran TA, Holloway RW. Metastatic leiomyosarcoma of the uterus with heterologous differentiation to malignant mesenchymoma. International Journal of Gynecological Pathology 2012; 31: 453-457.
  • Coleman RL, Sill MW, Lankes HA, Fader AN, Finkler NJ, Hoffman JS, Rose PG, Sutton GP, Drescher CW, McMeekin DS, Hu W, Deavers M, Godwin AK, Alpaugh RK, Sood AK. A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study. Gynecologic Oncology 2012; 127: 538-543.
  • Brudie LA, Gaia G, Ahmad S, Finkler NJ, Bigsby IV GE, Ghurani GB, Kendrick IV JE, Rakowski JA, Groton JH, Holloway RW.  Peri-operative outcomes of patients with stage IV endometriosis undergoing robotic-assisted laparoscopic surgery. Journal of Robotic Surgery 2012; 6: 317-322.
  • Bigsby IV GE, Holloway RW, Ahmad S, Sombeck MD, Ebra G, Finkler NJ. Chemoradiation with adjuvant hysterectomy for stage IB-2 cervical cancer: 10 year experince. Gynecological Surgery 2012; 9: 327-333.
  • Holloway RW, Molero Bravo RA, Rakowski JA, James JA, Jeppson CN, Ingersoll SB, Ahmad S. Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: A comparison of colorimetric and fluorescence imaging. Gynecologic Oncology 2012; 126: 25-29.
  • Ingersoll SB, Ahmad S, Finkler NJ, Edwards JR, Holloway RW. Cellular therapy for ovarian cancer: Experimental and clinical perspectives. Current Medicinal Chemistry 2012; 19: 3787-3793.
  • Dizon DS, Damstrup L, Finkler NJ, Lassen U, Celano P, Glasspool R, Crowley E, Lichtenstein HS, Knoblach P, Penson RT. Phase II activity of belinostat (PXD-101), carboplatin, and paclitaxel in women with previously treated ovarian cancer. International Journal of Gynecological Cancer 2012; 22: 979-986.
  • Rakowski JA, Ahmad S, Holloway RW. Use of pegylated liposomal doxorubicin (PLD) in the management of platinum-sensitive recurrent ovarian cancer: Current concepts. Expert Review of Anticancer Therapy 2011; 12: 31-40.
  • Ramirez PT, Adams S, Boggess JF, Burke WM, Frumovitz MM, Gardner GJ, Havrileski LJ, Holloway RW, Lowe MP, Magrina JF, Moore DH, Soliman PT, Yap S. Robotic-assisted surgery in gynecologic oncology: A Society of Gynecologic Oncology Consensus Statement Developed by the Society of Gynecologic Oncology’s Clinical Practice Robotics Task Force. Gynecologic Oncology 2012; 124: 180-184.
  • Ingersoll SB, Stoltzfus GP, Merchant MH, Ahmad, S, Edwards CR, Ahmed A, Oyer JR, Finkler NJ, Holloway RW, Edwards JR. Comparison of cytotoxic response against ovarian cancer by immune effector cells isolated and expanded from normal donors or ovarian cancer patients. Cytotherapy 2012; 14: 716-723.
  • Backes FJ, Brudie LA, Farrell MR, Ahmad S, Finkler NJ, Bigsby GE, O’Malley D, Cohn DE, Holloway RW, Fowler JM. Short- and long-term complications and morbidity of robotic-assisted comprehensive endometrial cancer staging. Gynecologic Oncology 2012; 125: 546-551.
  • Yue P, Zhang X, Paladino D, Sengupta B, Ahmad S, Holloway RW, Ingersoll SB, Turkson J. Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells. Oncogene 2012; 31: 2309-2322.
  • Secord AA, Pokrzywinski R, Havrilesky LJ, Puls LE, Holloway RW, Lewandowski GS, Higgins RV, Nycum LR, Kohler MF, Revicki DA. A multicenter, randomized, phase II clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin in sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer. Cancer 2012; 118: 3283-3293.
  • Holloway RW, Ahmad S. Robotic-assisted surgery in the management of endometrial cancer. Journal of Obstetrics & Gynaecology Research 2012; 38: 1-8.
  • Amirkhosravi A, Meyer T, Hatfield M. Desai H, Amaya M, Drexler A, Reyes E, Barranco J, Rathmann K, Bigsby IV G, Francis JL. Detection of circulating heparin in cancer patients after port flush of indwelling venous access devices: Implications for bevacizumab-associated thrombosis. Blood Coagulation & Fibrinolysis 2012; 23: 176-177.
  • Al-Badawi IA, Al-Aker M, Al-Subhi J, Bukhari I, Al-Omar O, Ahmad S. Robotic-assisted gynecologic/oncologic surgery: Experience of early cases in a Saudi Arabian tertiary care facility. Journal of Robotic Surgery 2012; 6: 125-130.
  • Ahmad A, Husain A, Ahmad S. Importance of sulfite oxidase in health and disease. In: Environmental Pollution: Ecology and Human Health (Reddy GR, Flora SJS, Basha RM, Eds.), Narosa Publishing House, New Delhi, 2012; pp. 61-71.
  • Ahmad S, Ingersoll SB, Ahmad A. Impact of environmental factors on thromboembolic disorders. In: Environmental Pollution: Ecology and Human Health (Reddy GR, Flora SJS, Basha RM, Eds.), Narosa Publishing House, New Delhi, 2012; pp. 156-165.
  • Holloway RW, Ahmad S. Standardization of one approach to robotic-assisted pelvic and aortic lymphadenectomy for patients with endometrial cancer including the morbidly obese. In: Proceedings of the 4th Annual Meeting of SERGS (Society of European Robotic Gynecological Surgery (Lambaudie E, Narducci F, Eds.), Marseille, France, 2012; pp. 35-43.
Back to Top

2011

  • Pokrzywinski R, Secord AA, Havrilesky LJ, Puls LE, Holloway RW, Lewandowski GS, Higgins RV, Nycum LR, Kohler MF, Revicki DA. Health-related quality of life outcomes of docetaxel/carboplatin combination therapy vs. sequential therapy with docetaxel then carboplatin  in patients with relapsed platinum-sensitive ovarian cancer: Results from a randomized clinical trial. Gynecologic Oncolology 2011; 123: 505-510.
  • Bevis KS, Straughn JM Jr, Kendrick JE, Walsh-Covarrubias J, Kilgore LC. Morbidity and mortality conference on obstetrics and gynecology: A tool for addressing the 6 core competencies. Journal of Graduate Medical Education 2011; 3: 100-103.
  • Ahmad S, Ansari AA. Therapeutic roles of heparin anticoagulants in cancer and related disorders. Medicinal Chemistry 2011; 7: 504-517.
  • Ingersoll SB, Ahmad S, Thoni ND, Ahmed FH, Monahan KA, Edwards JR. Targeting the  IL-6 pathway in multiple myeloma and its implications in cancer-associated gene hypermethylation. Medicinal Chemistry 2011; 7: 473-479.
  • Brudie LA, Ahmad S, Radi MJ, Finkler NJ. Metastatic choriocarcinoma in a viable intrauterine pregnancy treated with EMA-CO in third trimester. Journal of Reproductive Medicine 2011; 56: 359-364.
  • Basha R, Ingersoll SB, Sankpal UT, Ahmad S, Baker CH, Edwards JR, Holloway RW, Kaja S, Abdelrahim M. Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and survivin through suppressing specificity protein transcription factors. Gynecologic Oncology 2011; 122: 163-170.
  • Ingersoll SB, Ahmad S, Stoltzfus GP, Patel S, Radi MJ, Finkler NJ, Edwards JR, Holloway RW. Functional characterization of a fluorescent highly tumorigenic ovarian cancer line to test cellular therapy in experimental models. International Journal of Gynecological Cancer 2011; 21: 457-465.
  • Holloway RW, Brudie LA, Rakowski JA, Ahmad S. Robotic-assisted resection of liver and diaphragm recurrent ovarian carcinoma: Description of technique. Gynecologic Oncology 2011; 120: 419-422.
  • Basha RM, Baker CH, Sankpal U, Ahmad S, Safe S, Abdelrahim M. Therapeutic applications of non-steroidal anti-inflammatory drugs in cancer: Special emphasis on tolfenomic acid.Frontiers in Bioscience 2011; S3: 797-805.
Back to Top

2010

  • Gaia G, Holloway RW, Santoro L, Ahmad S, Di Silverio E, Spinillo A. Robotic-assisted hysterectomy for endometrial cancer compared with traditional laparoscopic and laparotomy approaches: A systematic review. Obstetrics & Gynecology 2010; 116: 1422-1431.
  • Holloway RW, Grendys EC, Lefebvre P, Vekeman F, McMeekin S. Tolerability, efficacy, and safety of pegylated liposomal doxorubicin in combination with carboplatin versus gemcitabine/carboplatin for the treatment of platinum-sensitive recurrent ovarian cancer: A systematic review. The Oncologist 2010; 15: 1073-1082.
  • Vergote I, Finkler NJ, Hall JB, Melnyk O, Edwards RP, Jones M, Keck JG, Meng L, Brown GL, Rankin EM, Burke JJ, Boccia RV, Runowicz CD, Rose PG. Randomized phase III study of canfosfamide in combination with pegylated liposomal doxorubicin compared with pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer. International Journal of Gynecological Cancer 2010; 20: 772-780.
  • Holloway RW. Extreme drug resistance assay does not influence survival in women with epithelial ovarian cancer [Letter-to-the-Editor]. Gynecologic Oncology 2010; 116: 147-148.
  • Sfakianos GP, Frederick PJ, Kendrick JE, Straughn JM, Kilgore LC, Huh WK. Robotic surgery in gynecologic oncology fellowship programs in the USA: A survey of fellows and fellowship directors. International Journal of Medical Robotics 2010; 6: 405-412.
  • Greer HO, Frederick PJ, Falls NM, Tapley EB, Samples KL, Kimball KJ, Kendrick JE, Conner MG, Novak L, Straughn JM Jr. Impact of a weekly multidisciplinary tumor board conference on the management of women with gynecologic malignancies. International Journal of Gynecological Cancer2010; 20: 1321-1325.
  • Ahmad A, Ahmad S. Screening and partial immunochemical characterization of sulfite oxidase from plant source. Indian Journal of Experimental Biology 2010; 48: 83-86.
  • Tetik S, Ahmad S, Alturfan AA, Fresko I, Disbudak M, Sahin Y, Aksoy H, Yardimci KT. Detection of oxidant stress in plasma of rheumatoid arthritis and primary osteoarthritis patients. Indian Journal of Biochemistry & Biophysics 2010; 47: 353-358.
  • Ahmad S. Modulation of serine proteases-mediated platelet activation by novel direct thrombin inhibitors. Journal of Medical Science 2010; 3: 44-53.
  • Pant AC, Diaz-Montes T, Tanner E, Ahmad S, Giuntoli RL, Holloway RW, Bristow RE. Correlation of extreme drug resistance assay results and progression-free survival following intra-peritoneal chemotherapy for advanced ovarian cancer. Journal of Chemotherapy 2010; 22: 270-274.
Back to Top

2009

  • Holloway RW, Ahmad S, DeNardis SA, Peterson LB, Sultana N, Bigsby GE IV, Pikaart DP, Finkler NJ. Robotic-assisted laparoscopic hysterectomy with lymphadenectomy for endometrial cancer: Analysis of surgical performance. Gynecologic Oncology 2009; 115: 447-452.
  • Vergote I, Finkler NJ, del Campo J, Hunter J, Matei D, Kavanagh J, Vermorken JB, Meng L, Jones M, Brown G, Kaye S, The Assist-1 Study Group. Phase 3 randomized study of canfosfamide (Telcyta®, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or –resistant ovarian cancer. European Journal of Cancer 2009; 45: 2324-2332.
  • Mendivil A, Holloway RW, Boggess JF. Emergence of robotic assisted surgery in gynecologic oncology. Gynecologic Oncology 2009; 114: S24-S31.
  • Sultana N, Pikaart DP, Ahmad S, DeNardis SA, Finkler NJ. Paraovarian leiomyosarcoma with scalp metastasis: A case report. European Journal of Gynaecological Oncology 2009; 30: 566-567.
  • Holloway RW, Patel SD, Ahmad S. Robotic surgery in gynecology. Scandinavian Journal of Surgery 2009; 98: 96-109.
  • Schilder RJ, Pathak HB, Lokshin AE, Holloway RW, Alvarez RD, Aghajanian C, Min H, Devarajan K, Ross E, Drescher CW, Godwin AK. Phase II trial of single agent cetuximab with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash. Gynecologic Oncology 2009; 113: 21-27.
  • Ingersoll SB, Patel S, Caballero L, Ahmad S, Edwards D, Holloway RW, Edwards JR. Synergistic cytotoxicity of interferon-a2b and interleukin-2 in combination with PBMC against ovarian cancer: Development of an experimental model for cellular therapy. Gynecologic Oncology 2009; 112: 192-198.
  • Ingersoll SB, Langer F, Walker JM, Meyer T, Robson T, Amaya M, Desai H, Francis JL, Amirkhosravi A.Deficiencies in the CD40 and CD154 receptor-ligand system reduce experimental lung metastasis. Clinical and Experimental Metastasis 2009; 26: 829-837.
  • Kannan M, Ahmad S, Fareed J, Saxena R. Diagnostic strategy in heparin-induced thrombocytopenia. Eastern Journal of Medicine 2009; 14: 78-83.
  • Leath CA III, Numnum TM, Kendrick JE IV,Frederick PJ, Rocconi RP, Conner MG, Straughn JM Jr. Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: Implications for adjuvant therapy. International Journal of Gynecological Cancer 2009; 19: 888-891.
  • Frederick PJ, Kendrick JE, Straughn JM Jr, Della Manna DL, Oliver PG, Lin HY, Grizzle WE, Stockard CR, Alvarez RD, Zhou T, LoBuglio AF, Buchsbaum DJ. Effect of TRA-8 anti-death receptor 5 antibody in combination with chemotherapy in an ex vivo human ovarian cancer model. International Journal of Gynecological Cancer 2009; 19: 814-819.
  • Sfakianos GP, Numnum TM, Halverson CB, Panjeti D, Kendrick JE, Straughn JM Jr. The risk of gastrointestinal perforation and/or fistula in patients with recurrent ovarian cancer receiving bevacizumab compared to standard chemotherapy: A retrospective cohort study. Gynecologic Oncology 2009; 114: 424-426.
  • Wetta LA, Matthews KS, Kemper ML, Whitworth JM, Fain ET, Huh WK, Kendrick JE, Straughn JM Jr. The management of cervical intraepithelial neoplasia during pregnancy: Is colposcopy necessary? Journal of Lower Genital Tract Disease 2009; 13: 182-185.
  • Whitworth JM, Matthews KS, Shipman KA, Numnum TM, Kendrick JE, Kilgore LC, Straughn JM Jr. The safety and efficacy of day 1 versus day 2 administration of pegfilgrastim in patients receiving myelosuppressive chemotherapy for gynecologic malignancies.Gynecologic Oncology 2009; 112: 601-614.
Back to Top